Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 55

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 3
Chunk 55
---
 (i) if additional patent applications covering
new technologies related to our product candidates will be filed; (ii) if and when patents will issue; (iii) the degree and range of protection
any issued patents will afford us against competitors, including whether third parties will find ways to invalidate or otherwise circumvent
our patents; (iv) whether any of our intellectual property will provide any competitive advantage; (v) whether any of our patents that
may be issued may be challenged, invalidated, modified, revoked, circumvented, found to be unenforceable or otherwise provide any competitive
advantage; (vi) whether others will obtain patents claiming inventions similar to those covered by our patents and patent applications;
or (vii) whether we will need to initiate or defend litigation or administrative proceedings which may be costly regardless of whether
we win or lose. The patent prosecution process is complex, expensive, time-consuming and inconsistent across jurisdictions. We may not
be able to file, prosecute, maintain, enforce, or license all necessary or desirable patent rights at a commercially reasonable cost or
in a timely manner. In addition, we may not pursue or obtain patent protection in all relevant markets. It is possible that we will fail
to identify important patentable aspects of our research and development efforts in time to obtain appropriate or any patent protection.
If we delay filing a patent application, and a competitor files a patent application on the same or a similar invention before we do,
our ability to secure patent rights may be limited. We may not be able to patent the invention at all. Even if we can patent the invention,
we may be able to patent only a limited scope of the invention, and the limited scope may be inadequate to protect our products, or to
block competitor products that are similar or adjacent to ours. Our earliest patent filings have been published. A competitor may review
our published patents and arrive at the same or similar technology advances for our products as we developed. If the competitor files
a patent application on such an advance before we do, then we may no longer be able to protect that aspect of our products and we may
require a license from the competitor. If the license is not available on commercially-viable terms, then we may not be able to launch
our product.

Going forward, the growth
of our business may depend in part on our ability to acquire or in-license additional proprietary rights. For example, our programs may
involve additional product candidates that may require the use of additional proprietary rights held by